Skip to main content
Skip to footer
Home
News Channels
Antibodies
Proteins and Peptides
Vaccines
DNA RNA and Cells
Small Molecules
More News
All News
Reports
Press Room
Contact Us
About Us
All Categories
Antibodies
DNA RNA and Cells
More News
Proteins and Peptides
Small Molecules
Vaccines
Any Word
All Words
Exact Phrase
Therapeutic Antibodies
Sep 2024
Degrader-Antibody Conjugates 2024: A Landscape Analysis of Stakeholders, Technologies, Pipeline and Partnering from an Industry Perspective
2.050,00€
Aug 2024
CD47 and SIRP-alpha Targeted Immunotherapy Pipeline Review
400,00€
Aug 2024
B7-H4 Targeted Antibody Therapy Pipeline Review
200,00€
Jul 2024
Tocilizumab (Actemra/RoActemra) Biosimilar Antibody Pipeline Review
200,00€
Jul 2024
PD-L1 x 4-1BB (CD137) Bispecific Antibody Pipeline Review
200,00€
Apr 2024
CD73 Inhibitor Pipeline Review
200,00€
Apr 2024
Claudin 18.2-Targeted Immunotherapeutics – a Competitor Analysis
430,00€
Apr 2024
Report Package: Claudin 18.2-Targeted Immunotherapeutics
2.150,00€
Mar 2024
CD38-Targeted Antibody & Cell Therapy Pipeline Review
300,00€
Mar 2024
TL1A Inhibitor Pipeline Review
100,00€
1
2
…
4
→
Any Word
All Words
Exact Phrase
Report categories
Antibody & Protein Sales
Antibody Technologies
Biosimilar Antibodies & Proteins
CAR T-Cells
Drug the Undruggable Technologies
Immuno-Oncology
mRNA Vaccines & Therapeutics
NK Cells & CAR Macrophages
Pipeline Database
RNA-Targeted Therapeutics
Target Pipelines
TCR T-Cells and Antibodies
Therapeutic Antibodies
Therapeutic Proteins & Peptides
